Showing Page:
1/3
1
Depression Emily
Student Name
Institution Affiliation
Instructor’s Name
Course
Date
Showing Page:
2/3
2
Response #2 Depression- Emily
Hello Karapetyan,
I appreciate you for taking the case of Emily upon your shoulders and giving yourself
to help her come out of the situation she is in currently. I like how you defined her case at first
as acute depression. Before doing anything else, that is the beginning point because one cannot
address a problem you have not identified or defined. Your choice of medication for her is
accurate for her depression state. I love how you make everything clear to her, even the dosage
to take and frequency. You have made a provision for an increase in the dosage after a while.
With that information, Emily is on a safe journey towards her recovery and healing. You have
impressed me by giving her family and the medical history the freedom to choose whether to
go by the antidepressant prescription or not. I like how you have linked Emily’s situation with
her mother, who had suffered depression earlier and was offered sertraline. The medication
worked for her effectively, posing a possibility of the same medicines working for Emily. I like
your addition that sertraline is safe than other antidepressants as a result of the low incidence
of adverse effects.
I love how you have made it quite clear that your treatment choice for Emily is not
affected by age. Sertraline indeed is one of the most prescribed antidepressants during
pregnancy (Gao et al., 2018). I agree with you that sertraline is a selective serotonin reuptake
inhibitor (SSRIs). You are very detailed in that you have outlined some of its side effects. I like
how you go a step further to provide other options since medication therapy is not enough.
You have made recommendations of pharmacological treatment which will be of great benefit
to Emily. You have impressed with the education you provided on the drug issues to create
awareness for Emily and other people.
Showing Page:
3/3
3
References
Gao, S. Y., Wu, Q. J., Sun, C., Zhang, T. N., Shen, Z. Q., Liu, C. X., ... & Zhao, Y. H.
(2018). Selective serotonin reuptake inhibitor use during early pregnancy and
congenital malformations: a systematic review and meta-analysis of cohort studies of
more than 9 million births. BMC medicine, 16(1), 1-14.

Unformatted Attachment Preview

1 Depression – Emily Student Name Institution Affiliation Instructor’s Name Course Date 2 Response #2 Depression- Emily Hello Karapetyan, I appreciate you for taking the case of Emily upon your shoulders and giving yourself to help her come out of the situation she is in currently. I like how you defined her case at first as acute depression. Before doing anything else, that is the beginning point because one cannot address a problem you have not identified or defined. Your choice of medication for her is accurate for her depression state. I love how you make everything clear to her, even the dosage to take and frequency. You have made a provision for an increase in the dosage after a while. With that information, Emily is on a safe journey towards her recovery and healing. You have impressed me by giving her family and the medical history the freedom to choose whether to go by the antidepressant prescription or not. I like how you have linked Emily’s situation with her mother, who had suffered depression earlier and was offered sertraline. The medication worked for her effectively, posing a possibility of the same medicines working for Emily. I like your addition that sertraline is safe than other antidepressants as a result of the low incidence of adverse effects. I love how you have made it quite clear that your treatment choice for Emily is not affected by age. Sertraline indeed is one of the most prescribed antidepressants during pregnancy (Gao et al., 2018). I agree with you that sertraline is a selective serotonin reuptake inhibitor (SSRIs). You are very detailed in that you have outlined some of its side effects. I like how you go a step further to provide other options since medication therapy is not enough. You have made recommendations of pharmacological treatment which will be of great benefit to Emily. You have impressed with the education you provided on the drug issues to create awareness for Emily and other people. 3 References Gao, S. Y., Wu, Q. J., Sun, C., Zhang, T. N., Shen, Z. Q., Liu, C. X., ... & Zhao, Y. H. (2018). Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC medicine, 16(1), 1-14. Name: Description: ...
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.
Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4